Status:
COMPLETED
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus.
Eligibility Criteria
Inclusion
- Patients at least 18 years of age and not older than 75 who have a specific type of diabetes called Type 2 Diabetes Mellitus
Exclusion
- Younger than 18 years of age or older than 75
- Any condition, which in the opinion of the investigator, may not be in the patient's best interest to participate
Key Trial Info
Start Date :
October 6 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2006
Estimated Enrollment :
521 Patients enrolled
Trial Details
Trial ID
NCT00094757
Start Date
October 6 2004
End Date
April 28 2006
Last Update
May 30 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.